We are consistently ranked by the legal directories as one of the leading law firms in Israel for mergers and acquisitions. The firm is involved in all types of M&A transactions ranging from the largest and most complex cross-border transactions to mid-size and smaller domestic acquisitions.

Our clients include the world’s largest corporations and financial institutions as well as corporate officers, investors, private equity funds, hedge funds and entrepreneurs from a wide variety of industry sectors, such as technology, telecommunications, life sciences, software, smart mobility and transportation, energy and infrastructure, financial services, cosmetics, media and insurance.

Our M&A team advises on all aspects of mergers and acquisitions, including:

  • Public and private acquisitions, by way of share purchase, asset purchase and merger.
  • Innovative and novel transaction structures, including those involving targets whose shares are listed on the Tel Aviv Stock Exchange (TASE), dual-listed or listed on a foreign stock exchange.
  • Tender and exchange offers, for cash, shares or mixed consideration.
  • Court-approved arrangements with shareholders and creditors.
  • Earn-outs.
  • Spin-offs, recapitalizations, leveraged buyouts, auction sales and distressed sales.
  • Auction sales, both from sell-side and buy-side.
  • Joint ventures and strategic alliances.
  • Acquisition and corporate finance, including convertible loans.
  • Obtaining tax rulings and all relevant regulatory consents in order to effect a change of control.
  • Contested takeovers.

Many of our partners are native English speakers dual-qualified (in the Israeli Bar Association as well as in foreign jurisdictions, who were originally trained and gained experience working in the corporate departments of leading New York and City of London law firms. From whichever jurisdiction the transaction is led, we are able to provide a seamless expert professional service to our clients at the same level found in the leading international law firms.


  • Acting as Israeli counsel to private equity funds Francisco Partners and IGP Capital in a transaction (LBO) to acquire LiveU, an Israeli based company that develops a system to replace satellites for live broadcasting.
  • Acting as Israeli counsel to Advent International in its USD 1.9 billion acquisition of NASDAQ-traded Forescout Technologies, a cyber security company which was originally founded in Israel.
  • Representing Minrav Projects, a public company, in its NIS 600 million acquisition via reverse triangular merger, whereby all of the shares of Minrav Projects will be purchased by a subsidiary of TASElisted Israel Canada and A.R Rem Projects.
  • Representing Rhythm One Plc on its merger of equals with Taptica, an Israeli company listed on the premium segment of the London Stock Exchange, via a statutory scheme of arrangement.
  • Representing the Israel Electric Corporation in a variety of transactional matters within tenders for the sale of the Alon Tavor, Ramat Hovav and Orot Rabin power stations.
  • Representing AIG, the W&I insurance provider for Taavura Group, in a major financial transaction regarding the sale of 50% of Taavura shares to the Phoenix Group Insurance Company Ltd. and others.
  • Representing Cardinal Health (NYSE: CAH) in the Israeli aspects of its USD 6.1 billion acquisition of Medtronic’s (NYSE: MDT) product portfolio of Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency.
  • Representing Chinese company Chengdu Kanghong Pharmaceutical Group, listed on the Shenzen Stock Exchange with a USD 6 billion market cap, in its investment in and staged acquisition of IOPtima, an Israeli subsidiary of BioLight Life Sciences Investments, traded on the TASE.
  • Representing US-based Danaher Corporation (NYSE: DHR), a Fortune 500 science and technology innovator, in its acquisition of Advanced Vision Technology, an Israeli company traded on the Frankfurt Stock Exchange.
  • Representing the Israel Infrastructures Fund (IIF) in a series of transactions in relation to its equity stake in Dalia Energies Power Ltd., the largest private power station operator in Israel, and the acquisition of the Via Maris (Palmachim) and Ashdod Desalination Plants.
  • Acting for France-based international cosmetics company, Groupe Rocher, in its multi-million EUR acquisition of Israel’s Sabon Group, which operates in the US, Europe and Japan.
  • Representing Orbbec 3D Technology International Inc., a Chinese-based developer and supplier of 3D cameras and motion sensing technology, in its acquisition of a minority stake in Newsight Ltd. (together with put and call options and shareholders’ agreement), an Israeli company which develops advanced CMOS image sensor chips for automotive, robotics, barcode scanners and AR/VR industries.





Chambers Global 2020: “Well-established firm that regularly advises international clients from the USA, China and Europe on inbound mergers and acquisitions of Israeli entities. Respected as local counsel on major global transactions. Experienced handling complex mandates including reverse triangular mergers and contested takeovers. Has broad sector-based knowledge including telecoms, healthcare and technology. Notable active assisting clients in the banking and finance industry with the disposition of assets.”
The European Legal 500 2020: “The lawyers at S. Horowitz & Co. have a wealth of experience in Israeli, US and UK law, as well as business practice, and, according to clients, one of its most enviable features is its 'top-class international connections'. Clients particularly rate Clifford Davis, who in late 2017 acted for Chengdu Kanghong Pharmaceutical Group in its acquisition of I-Optima, which was the client's first acquisition in Israel. Davis is also advising a US medical company on a significant transaction in Israel, and one of the largest transactions of its kind in the domestic market. Also recommended is Amit Steinman, who assisted Israel Infrastructure Fund with a series of share transactions with Dalia Energies Power. Keith Shaw and Shlomi Delgo are additional contacts in the department.”